Kopin (KOPN) 10-Q 11 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 28, 2015	8-May-15
Document Documentand Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	28-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Trading Symbol	KOPN
Entity Registrant Name	KOPIN CORP
Entity Central Index Key	771266
Current Fiscal Year End Date	-15
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		66,495,779

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 28, 2015	Dec. 27, 2014
Current assets:
Cash and equivalents	$12,460,936	$14,635,801
Marketable debt securities, at fair value	74,685,260	76,223,135
Accounts receivable, net of allowance of $191,000 and $266,000 in 2015 and 2014, respectively	4,420,993	3,758,832
Costs in Excess of Billings, Current	160,126	43,492
Inventory	3,654,213	4,081,886
Prepaid taxes	65,157	378,637
Prepaid expenses and other current assets	787,121	802,837
Notes, Loans and Financing Receivable, Gross, Current	14,950,003	0
Total current assets	111,183,809	99,924,620
Property, plant and equipment, net	4,246,687	4,589,421
Goodwill	947,450	976,451
Intangible assets, net	462,570	616,759
Other assets	2,366,581	1,900,828
Accounts and Notes Receivable, Net	0	14,933,335
Total assets	119,207,097	122,941,414
Current liabilities:
Accounts payable	3,524,566	5,503,734
Accrued payroll and expenses	1,268,813	1,985,691
Accrued warranty	716,000	716,000
Billings in excess of revenue earned	2,343,920	586,471
Other accrued liabilities	2,864,213	3,169,028
Deferred Tax Liabilities, Net, Current	1,282,000	1,282,000
Total current liabilities	11,999,512	13,242,924
Asset retirement obligations	297,309	311,187
Commitments and contingencies
Stockholders' equity:
Preferred stock, par value $.01 per share: authorized, 3,000 shares; none issued	0	0
Common stock, par value $.01 per share: authorized, 120,000,000 shares; issued 78,533,036 shares in 2015 and 77,731,604 shares in 2014; outstanding 63,088,667 shares in 2015 and 63,077,715 shares in 2014	751,909	751,832
Additional paid-in capital	325,499,893	324,625,694
Treasury stock (12,102,258 shares in 2015 and 2014, respectively, at cost)	-42,741,551	-42,741,551
Accumulated other comprehensive income	3,620,914	3,126,239
Accumulated deficit	-179,753,247	-175,915,255
Total Kopin Corporation stockholders' equity	107,377,918	109,846,959
Noncontrolling interest	-467,642	-459,656
Total stockholders' equity	106,910,276	109,387,303
Total liabilities and stockholders' equity	$119,207,097	$122,941,414

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 28, 2015	Dec. 27, 2014
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$0	$202,000
Preferred stock, par value	$0.01	$0.01
Preferred stock, authorized	3,000	3,000
Preferred stock, issued	0	0
Common stock, par value	$0.01	$0.01
Common stock, authorized	120,000,000	120,000,000
Common stock, issued	78,533,018	77,731,604
Common stock, outstanding	63,088,698	63,077,715
Treasury stock, shares	12,102,258	12,102,258

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (USD $)	3 Months Ended
	Mar. 28, 2015	Mar. 29, 2014
Revenues:
Net component revenues	$7,128,369	$4,227,760
Research and development revenues	1,456,622	467,010
Total revenues	8,584,991	4,694,770
Expenses:
Cost of component revenues	5,283,733	4,225,449
Research and development	4,860,192	5,086,284
Selling, general and administration	4,386,215	4,996,802
Total expenses	14,530,140	14,308,535
(Loss) income from operations	-5,945,149	-9,613,765
Other income and expense:
Interest income	209,664	238,172
Other income net	19,510	59,828
Foreign Currency Transaction Gain (Loss), Realized	-179,589	181,751
Gain (Loss) on Sale of Investments	2,142,421	0
Total other income and expense	2,192,006	479,751
(Loss) income before provision for income taxes, equity losses in unconsolidated affiliates and net loss (income) attributable to noncontrolling interest	-3,753,143	-9,134,014
Tax provision	-12,500	143,000
(Loss) income before equity loss in unconsolidated affiliates and net (loss) income of noncontrolling interest	-3,765,643	-8,991,014
Equity losses in unconsolidated affiliates	-47,443	-102,305
Net (loss) income	-3,813,086	-9,093,319
Net loss (income) attributable to the noncontrolling interest	-24,906	-41,097
Net (loss) income attributable to the controlling interest	($3,837,992)	($9,134,416)
Net (loss) income per share
Earnings Per Share, Basic	($0.06)	($0.15)
Earnings Per Share, Diluted	($0.06)	($0.15)
Weighted average number of common shares
Basic	63,083,652	62,530,202
Diluted	63,083,652	62,530,202

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $)	3 Months Ended
	Mar. 28, 2015	Mar. 29, 2014
Statement of Comprehensive Income [Abstract]
Net (loss) income	($3,813,086)	($9,093,319)
Foreign currency translation adjustments	14,422	-859,599
Holding (loss) gain on marketable securities	824,922	183,441
Reclassifications of gains in net (loss) income	-377,561	-14,085
Other Comprehensive Income (Loss), Net of Tax	461,783	-690,243
Comprehensive (loss) income	-3,351,303	-9,783,562
Comprehensive loss (income) attributable to the noncontrolling interest	57,798	8,986
Comprehensive (loss) income attributable to controlling interest	($3,293,505)	($9,774,576)

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)	Total	Common Stock	Additional Paid-in Capital	Stockholders' Equity, Total [Member]	Treasury Stock	Accumulated Other Comprehensive Income	Accumulated Deficit	Noncontrolling Interest
Beginning Balance at Dec. 27, 2014	$109,387,303	$751,832	$324,625,694	$109,846,959	($42,741,551)	$3,126,239	($175,915,255)	($459,656)
Beginning Balance (in shares) at Dec. 27, 2014		75,183,207
Stock-based compensation	874,276		874,276	874,276
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax	461,783			494,675		494,675		-32,892
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	0	7,718
Stock Issued During Period, Value, Stock Options Exercised	0	77	-77	0		0		0
Net loss	-3,813,086			-3,837,992			-3,837,992	24,906
Ending Balance at Mar. 28, 2015	$106,910,276	$751,909	$325,499,893	$107,377,918	($42,741,551)	$3,620,914	($179,753,247)	($467,642)
Ending Balance (in shares) at Mar. 28, 2015		75,190,925

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Mar. 28, 2015	Mar. 29, 2014
Cash flows from operating activities:
Net (loss) income	($3,813,086)	($9,093,319)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	681,899	932,974
Amortization of premium or discount on marketable debt securities	20,645	17,300
Stock-based compensation	997,464	1,126,957
Gain (Loss) on Sale of Investments	-2,142,421	0
Losses in unconsolidated affiliates	0	102,305
Deferred income taxes	0	-122,359
Foreign Currency Transaction Gain (Loss), before Tax	137,074	-157,642
Change in allowance for bad debt	-74,500	14,679
Other non-cash items	548,627	233,078
Changes in assets and liabilities:
Accounts receivable	-696,222	122,945
Inventory	-140,810	487,156
Prepaid expenses and other current assets	168,651	578,444
Accounts payable and accrued expenses	-3,071,919	-504,810
Billings in excess of revenue earned	1,907,449	117,491
Net cash used in operating activities	-5,477,149	-6,144,801
Cash flows from investing activities:
Other assets	-8,250	-14,127
Capital expenditures	-314,400	-444,372
Proceeds from sale of marketable debt securities	3,805,945	13,267,391
Purchase of marketable debt securities	-2,073,061	-8,444,398
Proceeds from Sale and Maturity of Other Investments	1,869,804	0
Proceeds from Sale of Machinery and Equipment	0	0
Net cash provided by investing activities	3,280,038	4,364,494
Net cash used in financing activities
Treasury stock purchases	0	-298,619
Proceeds from exercise of stock options	0	128,441
Net cash used in financing activities	0	-170,178
Effect of exchange rate changes on cash	22,246	5,429
Net decrease in cash and equivalents	-2,174,865	-1,945,056
Cash and equivalents:
Beginning of period	14,635,801
End of period	12,460,936
Supplemental disclosure of cash flow information:
Income taxes paid	50,000	57,000
Supplemental schedule of noncash investing activities:
Construction in progress included in accrued expenses	150,000	232,000
Proceeds from Warrant Exercises	$1,330,000	$0

BASIS_OF_PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Mar. 28, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Accounting [Text Block]	BASIS OF PRESENTATION
	The accompanying condensed consolidated financial statements include the accounts of Kopin Corporation, its wholly-owned subsidiaries, Kowon Technology Co., Ltd. (Kowon), a majority owned (93%) subsidiary located in Korea, Intoware Ltd. (Intoware), a majority owned (58%) subsidiary located in the United Kingdom, and eMDT America Inc. (eMDT), a majority owned (80%) subsidiary located in California (collectively, the Company). Ownership interests of Kowon, Intoware and eMDT not attributable to the Company are referred to as noncontrolling interests. All intercompany transactions and balances have been eliminated. The condensed consolidated financial statements for the three months ended March 28, 2015 and March 29, 2014 are unaudited and include all adjustments which, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended December 27, 2014.
	The Company ceased its production activities at its Kowon facility in 2013, but as of March 28, 2015 the closure of this facility did not meet the criteria for assets held for sale.
	During the second quarter of 2014, the Company paid approximately $0.3 million to acquire an additional 29% ownership in its eMDT subsidiary.
	The results of the Company's operations for any interim period are not necessarily indicative of the results of the Company's operations for any other interim period or for a full fiscal year.
	During the three months ended March 28, 2015, the change in the Company's accumulated other comprehensive income was the net of $0.1 million foreign currency translation adjustment, $0.8 million unrealized holding gains on marketable securities and $(0.4) million of reclassified holding gains.

CASH_AND_EQUIVALENTS_AND_MARKE

CASH AND EQUIVALENTS AND MARKETABLE SECURITIES	3 Months Ended
	Mar. 28, 2015
Cash and Equivalents and Marketable Securities Disclosure [Abstract]
CASH AND EQUIVALENTS AND MARKETABLE SECURITIES	CASH AND EQUIVALENTS AND MARKETABLE SECURITIES
	The Company considers all highly liquid, short-term debt instruments with original maturities of three months or less to be cash equivalents.
	Marketable debt securities consist primarily of certificates of deposit, medium-term corporate debt, and United States government and agency backed securities. The Company classifies these marketable debt securities as available-for-sale in “Marketable Debt Securities”. The Company records the amortization of premium and accretion of discount on marketable debt securities in the results of operations.
	The Company uses the specific identification method as a basis for determining cost and calculating realized gains and losses with respect to marketable debt securities. The gross gains and losses realized related to sales and maturities of marketable debt securities were not material during the three months ended March 28, 2015 and the year ended December 27, 2014.
	Investments in available-for-sale marketable debt securities are as follows at March 28, 2015 and December 27, 2014:
		Amortized Cost				Unrealized Gains				Unrealized Losses						Fair Value
		2015		2014		2015		2014		2015			2014			2015		2014
	U.S. government and agency backed securities	$	55,667,125	$	57,897,914	$	73,752	$	—	$	—		$	(200,772	)	$	55,740,877	$	57,697,142
	Corporate debt and certificates of deposit	18,995,265		18,564,823		—		—		(50,882		)	(38,830		)	18,944,383		18,525,993
	Total	$	74,662,390	$	76,462,737	$	73,752	$	—	$	(50,882	)	$	(239,602	)	$	74,685,260	$	76,223,135
	The contractual maturity of the Company’s marketable debt securities is as follows at March 28, 2015:
		Less than		One to		Greater than		Total
		One year		Five years		Five years
	U.S. government and agency backed securities	$	11,150,469	$	36,937,584	$	7,652,824	$	55,740,877
	Corporate debt and certificates of deposit	15,740,959		2,255,924		947,500		18,944,383
	Total	$	26,891,428	$	39,193,508	$	8,600,324	$	74,685,260
	The Company conducts a review of its marketable debt securities on a quarterly basis for the presence of other-than-temporary impairment (OTTI). The Company assesses whether OTTI is present when the fair value of a debt security is less than its amortized cost basis at the balance sheet date. Under these circumstances OTTI is considered to have occurred (1) if the Company intends to sell the security before recovery of its amortized cost basis; (2) if it is “more likely than not” the Company will be required to sell the security before recovery of its amortized cost basis; or (3) the present value of expected cash flows is not sufficient to recover the entire amortized cost basis.
	The Company further estimates the amount of OTTI resulting from a decline in the credit worthiness of the issuer (credit-related OTTI) and the amount of non credit-related OTTI. Noncredit-related OTTI can be caused by such factors as market illiquidity. Credit-related OTTI is recognized in earnings while noncredit-related OTTI on securities not expected to be sold is recognized in other comprehensive income (loss). The Company did not record an OTTI for the three months ended March 28, 2015 and March 29, 2014.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
	Mar. 28, 2015
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS
	Financial instruments are categorized as Level 1, Level 2 or Level 3 based upon the method by which their fair value is computed. An investment is categorized as Level 1 when its fair value is based on unadjusted quoted prices in active markets for identical assets that the Company has the ability to access at the measurement date. An investment is categorized as Level 2 if its fair market value is based on quoted market prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, based on observable inputs such as interest rates, yield curves, or derived from or corroborated by observable market data by correlation or other means. An investment is categorized as Level 3 if its fair value is based on assumptions developed by the Company about what a market participant would use in pricing the assets.
	The following table details the fair value measurements of the Company’s financial assets:
				Fair Value Measurement March 28, 2015 Using:
				Level 1		Level 2		Level 3
	Cash and Equivalents	$	12,460,936	$	12,460,936	$	—	$	—
	U.S. Government Securities	55,740,877		19,065,259		36,675,618		—
	Corporate Debt	6,779,034		—		6,779,034		—
	Certificates of Deposit	12,165,349		—		12,165,349		—
	Vuzix Corporation	1,908,957		1,908,957		—		—
	GCS Holdings	229,673		229,673		—		—
		$	89,284,826	$	33,664,825	$	55,620,001	$	—
				Fair Value Measurement December 27, 2014 Using:
				Level 1		Level 2		Level 3
	Cash and Equivalents	$	14,635,802	$	14,635,802	$	—	$	—
	U.S. Government Securities	57,697,142		21,218,340		36,478,802		—
	Corporate Debt	5,970,983		—		5,970,983		—
	Certificates of Deposit	12,555,010		—		12,555,010		—
	Vuzix Corporation	1,500,777		1,500,777		—		—
	GCS Holdings	180,347		180,347		—		—
		$	92,540,061	$	37,535,266	$	55,004,795	$	—
	The corporate debt consists of floating rate notes with a maturity that is over multiple years but has interest rates which are reset every three months based on the then current three month London Interbank Offering Rate (three month Libor). The Company validates the fair market values of the financial instruments above by using discounted cash flow models, obtaining independent pricing of the securities or through the use of a model which incorporates the three month Libor, the credit default swap rate of the issuer and the bid and ask price spread of the same or similar investments which are traded on several markets.
	The carrying amounts of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value because of their short-term nature.  If accrued liabilities were carried at fair value, these would be classified as Level 2 in the fair value hierarchy.

INVENTORY

INVENTORY	3 Months Ended
	Mar. 28, 2015
Inventory Disclosure [Abstract]
Inventory	INVENTORY
	Inventory is stated at the lower of cost (determined on the first-in, first-out) or market and consists of the following at March 28, 2015 and December 27, 2014:
		March 28,		December 27,
		2015		2014
	Raw materials	$	1,401,645	$	2,057,202
	Work-in-process	1,860,264		1,551,799
	Finished goods	392,304		472,885
		$	3,654,213	$	4,081,886

NET_LOSS_INCOME_PER_SHARE

NET (LOSS) INCOME PER SHARE	3 Months Ended
	Mar. 28, 2015
Earnings Per Share [Abstract]
Net (loss) Income per share	NET (LOSS) INCOME PER SHARE
	Basic net (loss) income per share is computed using the weighted average number of shares of common stock outstanding during the period less any non-vested restricted shares. Diluted earnings per common share, if applicable, is calculated using weighted average shares outstanding and contingently issuable shares, less weighted average shares reacquired during the period. The net outstanding shares are adjusted for the dilutive effect of shares issuable upon the assumed conversion of the Company’s common stock equivalents, which consist of outstanding stock options and unvested restricted stock units.
	Weighted average common shares outstanding used to calculate earnings per share are as follows:
		Three Months Ended
		March 28, 2015	March 29, 2014
	Weighted average common shares outstanding-basic	63,083,652	62,530,202
	Stock options and non-vested restricted common stock	—	—
	Weighted average common shares outstanding-diluted	63,083,652	62,530,202
	The following were not included in weighted average common shares outstanding-diluted because they are anti-dilutive or performance or market conditions had not been met at the end of the period.
		March 28, 2015	March 29, 2014
	Non-vested restricted common stock	3,342,111	3,349,148
	Stock options	130,000	524,600
	Total	3,472,111	3,873,748
	Not included in weighted average common shares outstanding-diluted are the warrants to purchase 148,000 shares of the Company’s common stock for $3.49 per share.

STOCKBASED_COMPENSATION

STOCK-BASED COMPENSATION	3 Months Ended
	Mar. 28, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION
	The fair value of non-vested restricted common stock awards is generally the market value of the Company’s common stock on the date of grant. The non-vested common stock awards require the employee to fulfill certain obligations, including remaining employed by the Company for one, two or four years (the vesting period) and in certain cases also require meeting either performance criteria or the Company’s stock achieving a certain price. For non-vested restricted common stock awards which solely require the recipient to remain employed with the Company, the stock compensation expense is amortized over the anticipated service period. For non-vested restricted common stock awards which require the achievement of performance criteria, the Company reviews the probability of achieving the performance goals on a periodic basis. If the Company determines that it is probable that the performance criteria will be achieved, the amount of compensation cost derived for the performance goal is amortized over the anticipated service period. If the performance criteria are not met, no compensation cost is recognized and any previously recognized compensation cost is reversed. The Company recognizes compensation costs on a straight-line basis over the requisite service period for time-vested awards.
	On February 13, 2015, the Company modified the termination date of certain restricted stock grants previously made to Dr. Fan, the Company’s President and Chief Executive Officer. In 2011, the Company granted Dr. Fan 260,000 shares of restricted stock which will vest upon the first 10 consecutive trading day period following the grant date during which the Company's common stock trades at a price equal to or greater than $5.25 subject to acceleration upon the occurrence of an acceleration event. This grant was originally set to terminate on September 12, 2016. In 2013, the Company granted compensation awards to its Dr. Fan that consisted of two grants of 150,000 shares of restricted stock each. One of the grants will vest at the end of the first 10 consecutive trading day period following the grant date during which the Company’s common stock trades at a price per share equal to or greater than $6.00. The other award will vest at the end of the first 10 consecutive trading day period following the grant date during which the Company’s common stock trades at a price per share equal to or greater than $7.00. Both are due to expire in 2023. On December 31, 2014, Dr. Fan entered into a 3 year employment agreement with the Company which expires on December 31, 2017. The Company has amended the three grants to now terminate on December 31, 2017, to be consistent with Dr. Fan's employment agreement.
	A summary of stock option award activity under the equity plans as of March 28, 2015 and changes during the three month period then ended is as follows (all options were vested as of March 28, 2015):
		Three months ended March 28, 2015
		Shares		Weighted
				Average
				Exercise
				Price
	Balance, December 27, 2014	130,500		$	3.49
	Options forfeited/canceled	(500	)	3.87
	Options exercised	—		—
	Balance, all exercisable, March 28, 2015	130,000		$	3.49
	The weighted average remaining contractual life of the outstanding options is less than one year. The Company has issued warrants to purchase 148,000 shares of the Company’s common stock for $3.49 per share.
	Non-Vested Restricted Common Stock
	A summary of the activity for non-vested restricted common stock awards as of March 28, 2015 and changes during the three month period then ended is presented below:
		Shares		Weighted
				Average
				Grant
				Fair
				Value
	Balance, December 27, 2014	2,551,631		$	3.75
	Granted	919,000		3.92
	Forfeited	(128,520	)	3.75
	Vested	—		—
	Balance, March 28, 2015	3,342,111		$	3.8
	Included within the non-vested restricted common stock table above is 50,000 awards granted for which the performance conditions have yet to be determined and therefore a grant date has not yet been established for the award.  No stock-based compensation expense has been recorded relating to this award during the three month period ended March 28, 2015.
	Subsequent to the year ended December 27, 2014, the Company identified an error in its calculation of the weighted average grant fair value of issued restricted stock outstanding as of December 27, 2014. The Company had disclosed a weighted average grant fair value of $4.41 in its Form 10-K for the year ended December 27, 2014, however the correct weighted average fair value was $3.75. The Company has revised the amount within the quarter ended March 28, 2015.
	Stock-Based Compensation
	The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three months ended March 28, 2015 and March 29, 2014 (no tax benefits were recognized):
		Three Months Ended
		March 28,			March 29,
		2015			2014
	Cost of component revenues	$	199,239		$	230,333
	Research and development	234,406			332,463
	Selling, general and administrative	563,819			564,161
	Total	$	997,464		$	1,126,957
	Unrecognized compensation expense for non-vested restricted common stock as of March 28, 2015 totaled $6.2 million and is expected to be recognized over a weighted average period of three years.

OTHER_ASSETS_AND_AMOUNTS_DUE_T

OTHER ASSETS AND AMOUNTS DUE TO / FROM AFFILIATES	3 Months Ended
	Mar. 28, 2015
Other Assets and Related Party Transactions Disclosure [Abstract]
OTHER ASSETS AND AMOUNTS DUE TO / FROM AFFILIATES	OTHER ASSETS AND NOTE RECEIVABLE
	During the second quarter of 2014, the Company wrote-off its $1.3 million investment in Kobrite. Prior to the write-off, the Company accounted for its 12% ownership interest using the equity method. One of the Company’s directors is a member of the Board of Directors of Bright LED, principal investor of KoBrite.
	The Company has recorded a $14.9 million note receivable resulting from the sale of its III-V product line and its investment in KTC, which is due January 16, 2016. The receivable is collateralized by certain assets of the buyer of the III-V product line. The buyer has outstanding debt and the repayment of the receivable is subject to the buyer remaining within its debt compliance obligations at the time of repayment.
	As of March 28, 2015 the Company had an investment in GCS Holdings with a fair market value of $0.2 million and an adjusted cost basis of $0.0 million. As of December 27, 2014, GCS Holdings had a fair market value of $0.2 million, with an adjusted cost basis of $0.0 million.
	As of December 27, 2014, the Company had an investment in Vuzix Corporation (“Vuzix”) with a fair market value of $1.5 million and adjusted cost basis of $0.0 million. On February 25, 2015, the Company acquired approximately 251,000 shares of Vuzix common stock through a cashless exercise of warrants. The Company received the warrants in August 2013 as part of a restructuring of debt owed by Vuzix to the Company. Upon receipt of the warrants, the Company should have recorded the value of the warrant of approximately $352,000 in its consolidated financial statements. Subsequently, the Company should have marked to market the warrants at the end of each reporting period. Had the Company recorded the warrants in its consolidated financial statements and marked to market the warrants as of December 28, 2013 and December 27, 2014, the Company would have recorded gains in its statement of operations of approximately $646,000 and $171,000, respectively. In the first quarter of 2015, the Company recorded the warrants in its consolidated financial statements and as a result recorded a gain of approximately $1.3 million with $817,000 attributed to prior periods. The value of the warrants as of August 2013, December 28, 2013 and December 27, 2014 was determined using the Black-Scholes pricing model. The Company does not believe the unrecorded gains were material to the consolidated financial statements as the loss from operations for the fiscal years ended December 28, 2013 and December 27, 2014 were $35.9 million and $28.7 million, respectively. As of March 28, 2015, the Company’s investment in Vuzix had a fair market value of $1.9 million with adjusted cost basis of $0.3 million.

ACCRUED_WARRANTY

ACCRUED WARRANTY	3 Months Ended
	Mar. 28, 2015
Product Warranties Disclosures [Abstract]
ACCRUED WARRANTY	ACCRUED WARRANTY
	The Company typically warrants its products against defect for 12 months. A provision for estimated future costs and estimated returns for credit relating to warranty is recorded in the period when product is shipped and revenue recognized, and is updated as additional information becomes available. The Company’s estimate of future costs to satisfy warranty obligations is based primarily on historical warranty expense experienced and a provision for potential future product failures. Changes in the accrued warranty for the three months ended March 28, 2015 are as follows:
	Balance, December 27, 2014	$	716,000
	Additions	128,000
	Claim and reversals	(128,000		)
	Balance, March 28, 2015	$	716,000

INCOME_TAXES

INCOME TAXES	3 Months Ended
	Mar. 28, 2015
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES
	The Company’s tax provision of approximately $12,500 for the three month period ended March 28, 2015 represents the net movement in estimated foreign withholding on anticipated future remitted earnings of an international subsidiary and state taxes. The Company’s tax benefit of approximately $143,000 for the three month period ended March 29, 2014 represents a reduction in estimated foreign withholding taxes due on an international subsidiary.
	As of March 28, 2015, the Company has available for tax purposes U.S. federal NOLs of approximately $71 million expiring through 2034. The Company has recognized a full valuation allowance on its domestic and certain foreign net deferred tax assets due to the uncertainty of realization of such assets. The Company has not historically recorded, nor does it intend to record the tax benefits from stock awards until realized. Unrecorded benefits from stock awards approximate $10 million.
	The Company’s income tax returns have not been examined by the Internal Revenue Service and are subject to examination for all years since 2001. State income tax returns are generally subject to examination for a period of 3 to 5 years after filing of the respective return. The state impact of any federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states.

SEGMENTS_AND_GEOGRAPHICAL_INFO

SEGMENTS AND GEOGRAPHICAL INFORMATION	3 Months Ended
	Mar. 28, 2015
Segment Reporting [Abstract]
SEGMENTS AND GEOGRAPHICAL INFORMATION	SEGMENTS AND GEOGRAPHICAL INFORMATION
	The Company’s chief operating decision maker is its Chief Executive Officer. The Company has determined it has two reportable segments, FDD, the manufacturer of its reflective display products for test and simulation products, and Kopin, which is comprised of Kopin Corporation, Kowon, Intoware and eMDT. The following table presents the Company’s reportable segment results (in thousands):
		Three Months Ended
		28-Mar-15
		Kopin				FDD			Total
	Revenues	$	7,586			$	999		$	8,585
	Net loss attributable to the controlling interest	(3,373		)		(465		)	(3,838		)
	Total assets	117,684				1,523			119,207
	Long-lived assets	4,067				180			4,247
	The total assets of Kopin is net of $5.2 million and $5.0 million in intercompany loans to FDD as of March 28, 2015 and December 27, 2014, respectively.
		Three Months Ended
		29-Mar-14
		Kopin				FDD			Total
	Revenues	$	3,902			$	793		$	4,695
	Net loss attributable to the controlling interest	(8,624		)		(510		)	(9,134		)
	Total assets	135,080				2,014			137,094
	Long-lived assets	4,927				423			5,350
	During the three month periods ended March 28, 2015 and March 29, 2014, the Company derived its sales from the following geographies (as a percentage of net revenues):
		Three Months Ended
		March 28, 2015			March 29, 2014
	United States	74	%		37	%
	Others	2	%		—	%
	Americas	76	%		37	%
	Asia-Pacific	16	%		47	%
	Europe	8	%		16	%
	Total Revenues	100	%		100	%

LITIGATION

LITIGATION	3 Months Ended
	Mar. 28, 2015
Commitments and Contingencies Disclosure [Abstract]
LITIGATION	LITIGATION
	The Company may engage in legal proceedings arising in the ordinary course of business. Claims, suits, investigations and proceedings are inherently uncertain and it is not possible to predict the ultimate outcome of such matters and our business, financial condition, results of operations or cash flows could be affected in any particular period.

CASH_AND_EQUIVALENTS_AND_MARKE1

CASH AND EQUIVALENTS AND MARKETABLE SECURITIES (Tables)	3 Months Ended
	Mar. 28, 2015
Cash and Equivalents and Marketable Securities Disclosure [Abstract]
Cash Cash Equivalents and Marketable Securities Table	Investments in available-for-sale marketable debt securities are as follows at March 28, 2015 and December 27, 2014:
		Amortized Cost				Unrealized Gains				Unrealized Losses						Fair Value
		2015		2014		2015		2014		2015			2014			2015		2014
	U.S. government and agency backed securities	$	55,667,125	$	57,897,914	$	73,752	$	—	$	—		$	(200,772	)	$	55,740,877	$	57,697,142
	Corporate debt and certificates of deposit	18,995,265		18,564,823		—		—		(50,882		)	(38,830		)	18,944,383		18,525,993
	Total	$	74,662,390	$	76,462,737	$	73,752	$	—	$	(50,882	)	$	(239,602	)	$	74,685,260	$	76,223,135
Marketable Debt Securities	The contractual maturity of the Company’s marketable debt securities is as follows at March 28, 2015:
		Less than		One to		Greater than		Total
		One year		Five years		Five years
	U.S. government and agency backed securities	$	11,150,469	$	36,937,584	$	7,652,824	$	55,740,877
	Corporate debt and certificates of deposit	15,740,959		2,255,924		947,500		18,944,383
	Total	$	26,891,428	$	39,193,508	$	8,600,324	$	74,685,260

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
	Mar. 28, 2015
Fair Value Disclosures [Abstract]
Fair Value Measurements of Financial Instruments	The following table details the fair value measurements of the Company’s financial assets:
				Fair Value Measurement March 28, 2015 Using:
				Level 1		Level 2		Level 3
	Cash and Equivalents	$	12,460,936	$	12,460,936	$	—	$	—
	U.S. Government Securities	55,740,877		19,065,259		36,675,618		—
	Corporate Debt	6,779,034		—		6,779,034		—
	Certificates of Deposit	12,165,349		—		12,165,349		—
	Vuzix Corporation	1,908,957		1,908,957		—		—
	GCS Holdings	229,673		229,673		—		—
		$	89,284,826	$	33,664,825	$	55,620,001	$	—
				Fair Value Measurement December 27, 2014 Using:
				Level 1		Level 2		Level 3
	Cash and Equivalents	$	14,635,802	$	14,635,802	$	—	$	—
	U.S. Government Securities	57,697,142		21,218,340		36,478,802		—
	Corporate Debt	5,970,983		—		5,970,983		—
	Certificates of Deposit	12,555,010		—		12,555,010		—
	Vuzix Corporation	1,500,777		1,500,777		—		—
	GCS Holdings	180,347		180,347		—		—
		$	92,540,061	$	37,535,266	$	55,004,795	$	—

INVENTORY_Tables

INVENTORY (Tables)	3 Months Ended
	Mar. 28, 2015
Inventory Disclosure [Abstract]
Inventory Stated at the Lower of Cost or Market	Inventory is stated at the lower of cost (determined on the first-in, first-out) or market and consists of the following at March 28, 2015 and December 27, 2014:
		March 28,		December 27,
		2015		2014
	Raw materials	$	1,401,645	$	2,057,202
	Work-in-process	1,860,264		1,551,799
	Finished goods	392,304		472,885
		$	3,654,213	$	4,081,886

NET_LOSS_INCOME_PER_SHARE_Tabl

NET (LOSS) INCOME PER SHARE (Tables)	3 Months Ended
	Mar. 28, 2015
Earnings Per Share [Abstract]
Weighted Average Common Shares Outstanding	Weighted average common shares outstanding used to calculate earnings per share are as follows:
		Three Months Ended
		March 28, 2015	March 29, 2014
	Weighted average common shares outstanding-basic	63,083,652	62,530,202
	Stock options and non-vested restricted common stock	—	—
	Weighted average common shares outstanding-diluted	63,083,652	62,530,202
Weighted Average Common Shares Outstanding-Diluted	The following were not included in weighted average common shares outstanding-diluted because they are anti-dilutive or performance or market conditions had not been met at the end of the period.
		March 28, 2015	March 29, 2014
	Non-vested restricted common stock	3,342,111	3,349,148
	Stock options	130,000	524,600
	Total	3,472,111	3,873,748

STOCKBASED_COMPENSATION_Tables

STOCK-BASED COMPENSATION (Tables)	3 Months Ended
	Mar. 28, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock- Based Compensation	A summary of stock option award activity under the equity plans as of March 28, 2015 and changes during the three month period then ended is as follows (all options were vested as of March 28, 2015):
		Three months ended March 28, 2015
		Shares		Weighted
				Average
				Exercise
				Price
	Balance, December 27, 2014	130,500		$	3.49
	Options forfeited/canceled	(500	)	3.87
	Options exercised	—		—
	Balance, all exercisable, March 28, 2015	130,000		$	3.49
NonVested Restricted Common Stock	A summary of the activity for non-vested restricted common stock awards as of March 28, 2015 and changes during the three month period then ended is presented below:
		Shares		Weighted
				Average
				Grant
				Fair
				Value
	Balance, December 27, 2014	2,551,631		$	3.75
	Granted	919,000		3.92
	Forfeited	(128,520	)	3.75
	Vested	—		—
	Balance, March 28, 2015	3,342,111		$	3.8
Stock-Based Compensation Expense	The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three months ended March 28, 2015 and March 29, 2014 (no tax benefits were recognized):
		Three Months Ended
		March 28,			March 29,
		2015			2014
	Cost of component revenues	$	199,239		$	230,333
	Research and development	234,406			332,463
	Selling, general and administrative	563,819			564,161
	Total	$	997,464		$	1,126,957

ACCRUED_WARRANTY_Tables

ACCRUED WARRANTY (Tables)	3 Months Ended
	Mar. 28, 2015
Product Warranties Disclosures [Abstract]
Accrued Warranty	Changes in the accrued warranty for the three months ended March 28, 2015 are as follows:
	Balance, December 27, 2014	$	716,000
	Additions	128,000
	Claim and reversals	(128,000		)
	Balance, March 28, 2015	$	716,000

SEGMENTS_AND_GEOGRAPHICAL_INFO1

SEGMENTS AND GEOGRAPHICAL INFORMATION (Tables)	3 Months Ended
	Mar. 28, 2015
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	The following table presents the Company’s reportable segment results (in thousands):
		Three Months Ended
		28-Mar-15
		Kopin				FDD			Total
	Revenues	$	7,586			$	999		$	8,585
	Net loss attributable to the controlling interest	(3,373		)		(465		)	(3,838		)
	Total assets	117,684				1,523			119,207
	Long-lived assets	4,067				180			4,247
	The total assets of Kopin is net of $5.2 million and $5.0 million in intercompany loans to FDD as of March 28, 2015 and December 27, 2014, respectively.
		Three Months Ended
		29-Mar-14
		Kopin				FDD			Total
	Revenues	$	3,902			$	793		$	4,695
	Net loss attributable to the controlling interest	(8,624		)		(510		)	(9,134		)
	Total assets	135,080				2,014			137,094
	Long-lived assets	4,927				423			5,350
Percentage of Net Revenues by Geographies	During the three month periods ended March 28, 2015 and March 29, 2014, the Company derived its sales from the following geographies (as a percentage of net revenues):
		Three Months Ended
		March 28, 2015			March 29, 2014
	United States	74	%		37	%
	Others	2	%		—	%
	Americas	76	%		37	%
	Asia-Pacific	16	%		47	%
	Europe	8	%		16	%
	Total Revenues	100	%		100	%

BASIS_OF_PRESENTATION_Details

BASIS OF PRESENTATION (Details) (USD $)	3 Months Ended
	Mar. 28, 2015
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax	$461,783
Reclassified holding gains	-400,000
Kowon Technology Corporation Limited [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent	93.00%
Intoware
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent	58.00%
eMDT
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent	80.00%
Payments to Acquire Additional Interest in Subsidiaries	300,000
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent	0.29
Accumulated Translation Adjustment [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	100,000
Accumulated Net Unrealized Investment Gain (Loss) [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax	$800,000

CASH_AND_EQUIVALENTS_AND_MARKE2

CASH AND EQUIVALENTS AND MARKETABLE SECURITIES (Details) (USD $)	Mar. 28, 2015	Dec. 27, 2014
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Debt Securities, Amortized Cost Basis	$74,662,390	$76,462,737
Unrealized Gains	73,752	0
Unrealized Losses	-50,882	-239,602
Fair Value	74,685,260	76,223,135
Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract]
Less than one year	26,891,428
One to five years	39,193,508
Greater than five years	8,600,324
Available-for-sale Securities	74,685,260
U.S. government and agency backed securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Debt Securities, Amortized Cost Basis	55,667,125	57,897,914
Unrealized Gains	73,752	0
Unrealized Losses	0	-200,772
Fair Value	55,740,877	57,697,142
Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract]
Less than one year	11,150,469
One to five years	36,937,584
Greater than five years	7,652,824
Available-for-sale Securities	55,740,877
Corporate debt and certificates of deposit
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Debt Securities, Amortized Cost Basis	18,995,265	18,564,823
Unrealized Gains	0	0
Unrealized Losses	-50,882	-38,830
Fair Value	18,944,383	18,525,993
Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract]
Less than one year	15,740,959
One to five years	2,255,924
Greater than five years	947,500
Available-for-sale Securities	$18,944,383

FAIR_VALUE_MEASUREMENTS_Detail

FAIR VALUE MEASUREMENTS (Details) (USD $)	Mar. 28, 2015	Dec. 27, 2014
Level 1
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	$33,664,825	$37,535,266
Level 1 | Money Markets, Cash and Equivalents
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	12,460,936	14,635,802
Level 1 | U.S. Government Securities
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	19,065,259	21,218,340
Level 1 | Vuzix [Member]
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	1,908,957	1,500,777
Level 1 | GCS [Member]
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	229,673	180,347
Level 2
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	55,620,001	55,004,795
Level 2 | U.S. Government Securities
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	36,675,618	36,478,802
Level 2 | Corporate Debt
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	6,779,034	5,970,983
Level 2 | Certificates of Deposit
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	12,165,349	12,555,010
Level 2 | Vuzix [Member]
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value		0
Level 3
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	0	0
Level 3 | Money Markets, Cash and Equivalents
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	0	0
Level 3 | U.S. Government Securities
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	0	0
Level 3 | Corporate Debt
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	0	0
Level 3 | Certificates of Deposit
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	0	0
Level 3 | Vuzix [Member]
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	0	0
Level 3 | GCS [Member]
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	0	0
Estimate of Fair Value
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	89,284,826	92,540,061
Estimate of Fair Value | Money Markets, Cash and Equivalents
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	12,460,936	14,635,802
Estimate of Fair Value | U.S. Government Securities
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	55,740,877	57,697,142
Estimate of Fair Value | Corporate Debt
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	6,779,034	5,970,983
Estimate of Fair Value | Certificates of Deposit
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	12,165,349	12,555,010
Estimate of Fair Value | Vuzix [Member]
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	1,908,957	1,500,777
Estimate of Fair Value | GCS [Member]
Fair Value Measurements [Line Items]
Financial Instruments, Owned, at Fair Value	$229,673	$180,347

INVENTORY_Details

INVENTORY (Details) (USD $)	Mar. 28, 2015	Dec. 27, 2014
Inventory Disclosure [Abstract]
Raw materials	$1,401,645	$2,057,202
Work-in-process	1,860,264	1,551,799
Finished goods	392,304	472,885
Inventory	$3,654,213	$4,081,886

NET_LOSS_INCOME_PER_SHARE_Deta

NET (LOSS) INCOME PER SHARE (Details) (USD $)	3 Months Ended
	Mar. 28, 2015	Mar. 29, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average common shares outstanding - basic	63,083,652	62,530,202
Stock options and non-vested restricted common stock	0	0
Weighted average common shares outstanding - diluted	63,083,652	62,530,202
Antidilutive securities excluded from computation of earnings per share	3,472,111	3,873,748
Issuance Of Warrants Shares	148,000
Exercise Price Of Warrants	$3.49
Non-vested restricted common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	3,342,111	3,349,148
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	130,000	524,600

STOCKBASED_COMPENSATION_Detail

STOCK-BASED COMPENSATION (Details) (USD $)	3 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 28, 2015
Class of Warrant or Right [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	150,000
Warrant issued to purchase company's stock	148,000
Warrant issued to purchase company's stock, exercise price	$3.49
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	50,000
Restricted Stock [Member]
Class of Warrant or Right [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	260,000
Unrecognized compensation cost related to nonvested stock awards	$6.20
Unrecognized compensation cost related to nonvested stock awards, period of recognition (in years)	3 years
Restricted Stock and Phantom Share Units [Member]
Class of Warrant or Right [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	10 days
Share-based Compensation Award, Tranche One
Class of Warrant or Right [Line Items]
Nonvested common stock awards employment obligations (in years)	1 year
Market Price Of Common Stock Range Low	$6
Share-based Compensation Award, Tranche Two
Class of Warrant or Right [Line Items]
Nonvested common stock awards employment obligations (in years)	2 years
Market Price Of Common Stock Range Low	$7
Share-based Compensation Award, Tranche Three
Class of Warrant or Right [Line Items]
Nonvested common stock awards employment obligations (in years)	4 years
Share-based Compensation Award, Tranche Three | Restricted Stock and Phantom Share Units [Member]
Class of Warrant or Right [Line Items]
Market Price Of Common Stock Range Low	$5.25

STOCKBASED_COMPENSATION_Summar

STOCK-BASED COMPENSATION - Summary of Award Activity under the Stock Option Plans and Changes (Details) (USD $)	3 Months Ended
	Mar. 28, 2015
Shares
Beginning Balance	130,500
Options forfeited/cancelled	-500
Options exercised	0
Ending Balance	130,000
Weighted Average Exercise Price
Beginning Balance	$3.49
Options forfeited/cancelled	$3.87
Options exercised	$0
Ending Balance	$3.49

STOCKBASED_COMPENSATION_Summar1

STOCK-BASED COMPENSATION - Summary of Activity for Nonvested Restricted Common Stock Awards (Details) (USD $)	3 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 28, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	50,000
Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	150,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to nonvested stock awards	6.2
Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	260,000
Non-vested restricted common stock
Shares
Beginning Balance	2,551,631
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	919,000
Forfeited	-128,520
Vested	0
Ending Balance	3,342,111
Weighted Average Grant Fair Value
Beginning Balance	3.75
Granted	3.92
Forfeited	3.75
Vested	0
Ending Balance	3.8

STOCKBASED_COMPENSATION_Expens

STOCK-BASED COMPENSATION - Expense Related to Employee Stock Options and Nonvested Restricted Common Stock Awards (Details) (USD $)	3 Months Ended
	Mar. 28, 2015	Mar. 29, 2014
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	$997,464	$1,126,957
Cost of product revenues
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	199,239	230,333
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	234,406	332,463
Selling, general and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	$563,819	$564,161

OTHER_ASSETS_AND_AMOUNTS_DUE_T1

OTHER ASSETS AND AMOUNTS DUE TO / FROM AFFILIATES (Details) (USD $)	3 Months Ended		12 Months Ended
	Mar. 28, 2015	Mar. 29, 2014	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012	Jan. 16, 2013
Schedule of Equity Method Investments [Line Items]
Accounts and Notes Receivable, Net						$14,900,000
Available-for-sale Securities	74,685,260
Class of Warrant or Right, Unissued	251,000
Warrants and Rights Outstanding	352,000
Prior Period Reclassification Adjustment	1,300,000		171,000	646,000	817,000
Net (loss) income	-3,813,086	-9,093,319	28,700,000	35,900,000
Ko Brite (Member)
Schedule of Equity Method Investments [Line Items]
Carrying value of the investment	1,300,000
Company's ownership percentage	12.00%
Vuzix [Member]
Schedule of Equity Method Investments [Line Items]
Available-for-sale Securities	1,900,000		1,500,000
Available-for-sale Equity Securities, Amortized Cost Basis	300,000		0
GCS Holdings [Member]
Schedule of Equity Method Investments [Line Items]
Available-for-sale Securities	200,000		200,000
Available-for-sale Equity Securities, Amortized Cost Basis	$0		$0

ACCRUED_WARRANTY_Details

ACCRUED WARRANTY (Details) (USD $)	3 Months Ended
	Mar. 28, 2015
Product Warranties Disclosures [Abstract]
Product warranty term	12 months
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning Balance	$716,000
Additions	128,000
Claim and reversals	-128,000
Ending Balance	$716,000

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	3 Months Ended
	Mar. 28, 2015	Mar. 29, 2014	Mar. 30, 2013
Income Taxes [Line Items]
State income and foreign tax expenses	$12,500	($143,000)	$143,000
Net operating loss carryforwards available for tax purposes	71,000,000
Unrecorded benefits from stock award	$10,000,000
Minimum
Income Taxes [Line Items]
State income tax returns examination period	3 years
Maximum
Income Taxes [Line Items]
State income tax returns examination period	5 years
The state impact of any federal changes, subject to examination by various states (in years)	1 year

SEGMENTS_AND_GEOGRAPHICAL_INFO2

SEGMENTS AND GEOGRAPHICAL INFORMATION (Details) (USD $)	3 Months Ended
	Mar. 28, 2015	Mar. 29, 2014	Dec. 27, 2014	Sep. 28, 2013
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$8,584,991	$4,694,770
Net Income (Loss) Attributable to Parent	-3,837,992	-9,134,416
Assets	119,207,097		122,941,414
Debt of Subsidiary, Not Assumed	5,200,000			5,000,000
Percentage of total revenue	100.00%	100.00%
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of total revenue	74.00%	37.00%
All Others
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of total revenue	2.00%	0.00%
Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of total revenue	76.00%	37.00%
Asia-Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of total revenue	16.00%	47.00%
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of total revenue	8.00%	16.00%
Segment, Continuing Operations [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	8,585	4,695,000
Net Income (Loss) Attributable to Parent	-3,838	-9,134,000
Assets	119,207	137,093,895
Long-Lived Assets	4,247	5,350,375
Segment, Continuing Operations [Member] | Kopin United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	7,586	3,902,000
Net Income (Loss) Attributable to Parent	-3,373	-8,624,000
Assets	117,684	135,079,692
Long-Lived Assets	4,067	4,926,972
Segment, Continuing Operations [Member] | Forth Dimension Displays Limited [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	999	793,000
Net Income (Loss) Attributable to Parent	-465	-510,000
Assets	1,523	2,014,203
Long-Lived Assets	$180	$423,403